The 4th Annual Conference of the Japanese Society of Preemptive Clinical Medicine .

*This event has ended*.

The 4th Annual Conference of the Japanese Society of Preemptive Medicine will be held on November 20-21, 2012.
We are pleased to announce that Symbiosis Laboratories will have a booth at the conference.

The Japanese Society of Preemptive Clinical Medicine, a general foundation, was established in April 2018, and several doctors who are members of our study group are serving on its board of directors, and several of our members will be speaking at the event.

The presentation on intestinal flora transplantation will be given by Dr. Masahiko Shirotani, Director of on November 21 (Sunday) from 14:30 on the second day.
Presentation titled “The Potential of Intestinal Flora Transplantation (FMT) in the Treatment of Autistic Children.”
Dr. Masahiko Shirotani, Director of Luke’s Ashiya Clinic, will give a presentation.

Outline of the event

schedule

Saturday, November 20 – Sunday, November 21, 2021

venue

Osaki Brightcore Hall (5-5-15, Kita-Shinagawa, Shinagawa-ku, Tokyo)
Online delivery
*If you wish to participate online, please register here.

congress president

Zen Tanaka (President, Tanaka Clinic, Jinzenkai Medical Corporation)

vice president (of a convention)

Yoshitaka Fukuzawa (Professor, Aichi Medical University)

Honorary President

Yoshitaka Fukuzawa (Professor, Aichi Medical University)
Noriaki Man (President, Medical Corporation Iryushinkai Yorozu Clinic)

Conference Theme

Preemptive Medicine for a New Era (Preemptive Medicine to the World)

point (e.g. of a statement)

When faced with patients suffering from cancer and other diseases, we physicians on the front lines of clinical practice must take some kind of therapeutic action. We have a role to seek preemptive medical treatment widely overseas and disclose it to a wide range of Japanese physicians, not merely within the framework of insured treatment in accordance with the medical insurance system. It is necessary to achieve this goal through the participation of a cross-section of medical professionals such as doctors and dentists, companies such as supplement manufacturers and medical equipment manufacturers, and cancer survivors.

For more information on participation fees, time schedule, registration, etc.